Fig. 2From: Rare, late onset of immune checkpoint inhibitor-induced type 1 diabetes mellitus in a patient with small-cell lung cancer treated with serplulimab: a case report and review of the literatureBlood glucose levels of the patient during the treatment processBack to article page